RxDoctor Payments Data

Necia Garrett, APRN

Family · Henderson, KYNPI 1710342456

Payments from drug & device makers

$5,258in general payments, 2019–2025

Across 364 payments — averaging $14.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$555
  • Pfizer$427
  • Lilly USA, LLC$383
  • GSK$319
  • Otsuka America Pharmaceutical, Inc.$246
  • plus $2K from 38 others

What the payments were for

  • Food & beverage$5,258100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,258 in reported general payments places this provider in the 90th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$41,768
Medicare patients
210
Services billed
1,026

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban77$66,066
JardianceEmpagliflozin53$50,189
OzempicSemaglutide39$41,090
FarxigaDapagliflozin Propanediol65$40,645
RexultiBrexpiprazole18$34,760
JanuviaSitagliptin Phosphate46$33,091
VraylarCariprazine Hcl22$33,077
MounjaroTirzepatide24$24,790
Trelegy ElliptaFluticasone/Umeclidin/Vilanter34$24,014
Nurtec OdtRimegepant Sulfate20$23,730
TrulicityDulaglutide20$23,335
Breztri AerosphereBudesonide/Glycopyr/Formoterol26$22,487
MyrbetriqMirabegron22$16,906
TrintellixVortioxetine Hydrobromide21$14,229
Repatha SureclickEvolocumab13$9,529

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Nurtec Odt$427$89,79697 claims
AstraZenecaFarxiga, Breztri Aerosphere$233$63,13391 claims
Boehringer IngelheimJardiance$152$50,18953 claims
Lilly USA, LLCMounjaro, Trulicity$383$48,12544 claims
Novo NordiskOzempic$555$41,09039 claims
Otsuka America Pharmaceutical, Inc.Rexulti$246$34,76018 claims
AbbVieVraylar, Synthroid$1,211$34,58048 claims
MerckJanuvia$33$33,09146 claims
GSKTrelegy Ellipta$319$24,01434 claims
Astellas Pharma US IncMyrbetriq$51$16,90622 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$115$14,22921 claims
Teva Pharmaceuticals USA, Inc.Acyclovir$89$1,13016 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,374 family providers in Kentucky.

Other family in Henderson

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →